JP2024502632A5 - - Google Patents
Info
- Publication number
- JP2024502632A5 JP2024502632A5 JP2023542493A JP2023542493A JP2024502632A5 JP 2024502632 A5 JP2024502632 A5 JP 2024502632A5 JP 2023542493 A JP2023542493 A JP 2023542493A JP 2023542493 A JP2023542493 A JP 2023542493A JP 2024502632 A5 JP2024502632 A5 JP 2024502632A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- sequence
- seq
- nucleic acid
- chimeric antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110036169.2A CN113234682B (zh) | 2021-01-12 | 2021-01-12 | 靶向cd7的工程化免疫细胞、嵌合抗原受体、cd7阻断分子及应用 |
| CN202110036169.2 | 2021-01-12 | ||
| PCT/CN2021/133817 WO2022151851A1 (zh) | 2021-01-12 | 2021-11-29 | 靶向cd7的工程化免疫细胞、嵌合抗原受体、cd7阻断分子及应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024502632A JP2024502632A (ja) | 2024-01-22 |
| JP2024502632A5 true JP2024502632A5 (https=) | 2024-10-02 |
Family
ID=77130068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023542493A Pending JP2024502632A (ja) | 2021-01-12 | 2021-11-29 | Ｃｄ７を標的とする改変免疫細胞、キメラ抗原受容体、ｃｄ７ブロッキング分子およびその応用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240075143A1 (https=) |
| EP (1) | EP4279585A4 (https=) |
| JP (1) | JP2024502632A (https=) |
| KR (1) | KR20230134133A (https=) |
| CN (3) | CN113234682B (https=) |
| AU (1) | AU2021418636A1 (https=) |
| CA (1) | CA3204370A1 (https=) |
| WO (1) | WO2022151851A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113234682B (zh) * | 2021-01-12 | 2023-02-21 | 上海雅科生物科技有限公司 | 靶向cd7的工程化免疫细胞、嵌合抗原受体、cd7阻断分子及应用 |
| CN114716564B (zh) * | 2021-12-20 | 2023-02-28 | 四川大学华西医院 | 基于sectm1构建的嵌合抗原受体免疫细胞制备及其应用 |
| EP4463135A2 (en) | 2022-01-10 | 2024-11-20 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
| CN114560943B (zh) * | 2022-02-28 | 2022-12-16 | 先进生物(苏州)有限公司 | Cd7-car-t细胞及其制备方法和应用 |
| CN115806618B (zh) * | 2022-03-30 | 2025-11-11 | 河北森朗生物科技有限公司 | 一种抗cd7的纳米抗体vhh12及其相关产品、方法和用途 |
| WO2024040194A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
| CN116003631B (zh) * | 2022-11-15 | 2024-01-26 | 江苏元晟生物科技有限公司 | 靶向cd7的人源化抗体及其应用 |
| WO2024119157A1 (en) | 2022-12-02 | 2024-06-06 | Sana Biotechnology, Inc. | Lipid particles with cofusogens and methods of producing and using the same |
| EP4716750A1 (en) | 2023-05-23 | 2026-04-01 | Sana Biotechnology, Inc. | Tandem fusogens and related lipid particles |
| AU2024279278A1 (en) | 2023-05-31 | 2025-12-18 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| US20250127728A1 (en) | 2023-10-05 | 2025-04-24 | Capstan Therapeutics, Inc. | Constrained Ionizable Cationic Lipids and Lipid Nanoparticles |
| WO2025076113A1 (en) | 2023-10-05 | 2025-04-10 | Capstan Therapeutics, Inc. | Ionizable cationic lipids with conserved spacing and lipid nanoparticles |
| US20250302763A1 (en) | 2024-02-22 | 2025-10-02 | Capstan Therapeutics, Inc. | Immune engineering amplification |
| WO2025184529A1 (en) | 2024-03-01 | 2025-09-04 | Sana Biotechnology, Inc. | Viral particles with fusogen display and related compositions and methods |
| WO2025217452A1 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Constrained ionizable cationic lipids and lipid nanoparticles |
| WO2025217454A2 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Ionizable cationic lipids and lipid nanoparticles |
| CN120865430A (zh) * | 2024-04-30 | 2025-10-31 | 合源生物科技(天津)有限公司 | 一种增强型嵌合抗原受体及其应用 |
| CN120866421B (zh) * | 2025-09-28 | 2026-03-03 | 深圳细胞谷生物医药有限公司 | 无电转、批量制备免疫细胞治疗产品的方法及其产品 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5590000A (en) * | 1999-05-28 | 2000-12-18 | Immunex Corporation | Ligand for cd7, and methods for use thereof |
| US20040202675A1 (en) * | 2002-12-09 | 2004-10-14 | Duke University | Vaccine adjuvant |
| KR102763121B1 (ko) * | 2015-02-06 | 2025-02-04 | 내셔널 유니버시티 오브 싱가포르 | 치료적 면역 세포의 효능의 향상 방법 |
| JP7237449B2 (ja) * | 2015-02-27 | 2023-03-13 | アイセル・ジーン・セラピューティクス・エルエルシー | 血液系腫瘍を標的としたキメラ抗体受容体（ＣＡＲｓ）の構成およびその使用方法 |
| WO2017213979A1 (en) * | 2016-06-06 | 2017-12-14 | St. Jude Children's Research Hospital | Anti-cd7 chimeric antigen receptor and method of use thereof |
| CN109562126A (zh) * | 2016-06-24 | 2019-04-02 | 美商生物细胞基因治疗有限公司 | 嵌合抗原受体(car)、组合物及其使用方法 |
| NZ752984A (en) * | 2016-11-22 | 2026-03-27 | Nat Univ Singapore | Blockade of cd7 expression and chimeric antigen receptors for immunotherapy of t-cell malignancies |
| GB201622044D0 (en) * | 2016-12-22 | 2017-02-08 | Ucl Business Plc | T cell-targeted T cells |
| CN110944652A (zh) * | 2017-06-12 | 2020-03-31 | 爱莫里大学 | T细胞抗原靶向的嵌合抗原受体(car)以及在细胞疗法中的用途 |
| MA53877A (fr) * | 2018-11-14 | 2022-01-19 | MediSix Therapeutics Pte Ltd | Vecteurs à deux gènes pour la génération de cellules car-t et utilisations associées |
| CN115925976A (zh) * | 2019-11-21 | 2023-04-07 | 博生吉医药科技(苏州)有限公司 | Cd7-car-t细胞及其制备和应用 |
| CN113234682B (zh) * | 2021-01-12 | 2023-02-21 | 上海雅科生物科技有限公司 | 靶向cd7的工程化免疫细胞、嵌合抗原受体、cd7阻断分子及应用 |
-
2021
- 2021-01-12 CN CN202110036169.2A patent/CN113234682B/zh active Active
- 2021-01-12 CN CN202211632999.2A patent/CN115786271B/zh active Active
- 2021-01-12 CN CN202211663129.1A patent/CN115947852A/zh active Pending
- 2021-11-29 EP EP21919042.8A patent/EP4279585A4/en active Pending
- 2021-11-29 KR KR1020237027583A patent/KR20230134133A/ko active Pending
- 2021-11-29 WO PCT/CN2021/133817 patent/WO2022151851A1/zh not_active Ceased
- 2021-11-29 AU AU2021418636A patent/AU2021418636A1/en active Pending
- 2021-11-29 JP JP2023542493A patent/JP2024502632A/ja active Pending
- 2021-11-29 CA CA3204370A patent/CA3204370A1/en active Pending
-
2023
- 2023-07-12 US US18/351,466 patent/US20240075143A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024502632A5 (https=) | ||
| JP2020517295A5 (https=) | ||
| JP2021094037A5 (https=) | ||
| CN112029001B (zh) | 靶向nk激活性受体的嵌合抗原受体 | |
| JP2023527049A5 (https=) | ||
| JP2022534680A5 (https=) | ||
| EP3333183B1 (en) | Targeted/immunomodulatory fusion proteins and methods for making same | |
| JP2018535701A5 (https=) | ||
| JP2025028239A5 (https=) | ||
| IL277079B1 (en) | Cartyrin compositions and methods for use | |
| JP2021087455A5 (https=) | ||
| JP2022501043A5 (https=) | ||
| HRP20231542T1 (hr) | Kimerni antigenski receptori koji ciljaju bcma i postupci njihove uporabe | |
| JP2020533958A5 (https=) | ||
| JP2018527014A5 (https=) | ||
| FI3710067T3 (fi) | Polypeptidejä sisältävä d-domeeni ja niiden käyttötarkoitukset | |
| KR20230011959A (ko) | 동종이계 이식을 위한 조작된 면역 세포 | |
| JP2021532742A5 (https=) | ||
| JP2017524367A5 (https=) | ||
| JP2024513906A5 (https=) | ||
| JP2024527557A5 (https=) | ||
| JP2024534847A5 (https=) | ||
| JP2025505546A5 (https=) | ||
| CN115521917A (zh) | 工程化免疫细胞及其用途 | |
| CN115785279A (zh) | 包含新型共刺激结构域的嵌合抗原受体及其用途 |